Hydroxychloroquine & Pregnancy: Risks, Safety & Medical Guidance

Hydroxychloroquine (HCQ) crosses the placenta and reaches the fetus. While historically used in pregnancy for lupus and malaria, current evidence suggests potential risks.

Potential Risks

  • Congenital anomalies: Some studies associate HCQ with cardiac defects.
  • Low birth weight: Observed in some cohorts.
  • Miscarriage risk: Data are mixed; underlying disease (lupus) also contributes.

Current Recommendations

  • Do not start HCQ during pregnancy unless benefits clearly outweigh risks.
  • If already taking HCQ and become pregnant: Do not stop abruptly. Consult your rheumatologist and OB/GYN immediately. Continuation may be advised for disease control (especially lupus), as flare risks may exceed drug risks.
  • Regular fetal monitoring (ultrasounds, echocardiograms) is recommended.

Bottom Line

Decisions must be individualized. Never adjust medication without specialist guidance.

Pregnancy & Health - Related Articles